CBA Profit Growth Slowest Since 2009, Bad-Debt Charges Climb
(Bloomberg) -- Commonwealth Bank of Australia, the nation's largest lender, posted a 3 percent increase in full-year profit to a record for the seventh consecutive year, driven by higher earnings at its retail banking unit.
Cash profit, which excludes one-time items, rose to A$9.45 billion ($7.25 billion) from A$9.14 billion a year earlier, the Sydney-based lender said in a regulatory filing Wednesday. That was the slowest annual profit growth since a drop in the measure in 2009 and compares with the A$9.5 billion mean estimate of 13 analysts, according to data compiled by Bloomberg.
Australia's biggest banks are drawing the curtain on a streak of record profits bolstered by foreign lenders exiting the market, declines in impairments to unprecedented lows and cost cuts. The nation's big four lenders are also facing a regulatory clampdown on mortgages to combat runaway housing prices and bracing themselves to meet demands to boost capital and liquidity.
“The headwinds faced by Australian banks are well documented,” David Ellis, a Sydney-based analyst at Morningstar Inc., said by phone. “It's a pretty solid result in challenging conditions and I expect the bank to resort to a wide range of initiatives including cost cuts and interest-rate changes to maintain profit growth.”
Profit fell at all units except in the retail lending, and business and private banking divisions, Commonwealth Bank said. The retail banking unit's profit rose 11 percent, while earnings from its institutional banking and markets business declined 9 percent. Wealth-management income dropped 6 percent, the bank said.
“Income growth inside and outside Australia remains weak, so people are not feeling better off,” Chief Executive Officer Ian Narev said in the statement. “When combined with ongoing global economic and political uncertainty this makes households and businesses cautious, and hesitant to respond to monetary stimulus.”
The Reserve Bank of Australia last week dropped its cash rate by a quarter point to an unprecedented low of 1.5 percent to stoke inflation and wage growth.
Bad-debt charges rose 27 percent from a year earlier to A$1.26 billion, due to higher provisioning for its exposure to the resources, commodity and dairy sectors, it said.
Net interest margin, a measure of lending profitability, fell to 2.07 percent from 2.09 percent a year earlier.
The common equity Tier 1 ratio, a measure of a bank's ability to absorb future losses, rose to 10.6 percent at the end of June from 10 percent three months earlier, Commonwealth Bank said. It raised A$5.1 billion last year by selling new shares to meet new regulatory requirements.
Customer deposits made up 66 percent of total funding from 64 percent six months earlier, and the net stable funding ratio exceeded 100 percent.
The bank, the nation's biggest mortgage lender with a 25 percent market share, will pay a final dividend of A$2.22 a share compared with analyst estimates of A$2.32.
Commonwealth Bank's business year ends in June, compared with September for its main competitors. Australia & New Zealand Banking Group Ltd. Tuesday said its cash profit in the first nine months slipped 3 percent. National Australia Bank Ltd. reports its quarterly update Aug. 15. Westpac Banking Corp. doesn't provide one.
Commonwealth Bank shares were little changed as of 10:27 a.m. in Sydney. They have dropped about 8 percent this year compared with a 7.6 percent decline in the bank index and a 4.7 percent increase in the benchmark S&P/ASX 200 Index.
To contact the reporter on this story: Narayanan Somasundaram in Sydney at nsomasundara@bloomberg.net. To contact the editors responsible for this story: Garfield Reynolds at greynolds1@bloomberg.net, Andreea Papuc, Russell Ward
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets